Topical tacrolimus. Article

cited authors

  • Frankel, SJ; Kerdel, FA

fiu authors

abstract

  • Tacrolimus, available for intravenous, oral and now topical administration, is a potent immunosuppressive agent with the ability to block the production of Interleukin-2 (IL-2) and inhibit T-cell proliferation. Originally developed for use in organ transplantation, it is currently being studied for the treatment of inflammatory dermatoses. The US FDA recently approved tacrolimus ointment (Protopic (R), Fujisawa) for the treatment of atopic dermatitis.

publication date

  • January 1, 2001

volume

  • 6

issue

  • 4